4//SEC Filing
CUMBERLAND PHARMACEUTICALS INC 4
Accession 0001209191-17-020844
$CPIXCIK 0001087294operating
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 5:00 PM ET
Size
4.5 KB
Accession
0001209191-17-020844
Insider Transaction Report
Form 4
Lawrence Thomas R
Director
Transactions
- Sale
Common Stock
2017-03-13$6.24/sh−20,781$129,673→ 6,000 total
Footnotes (1)
- [F1]Shares transferred to accredited investor
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeoperating
IncorporatedTN
Related Parties
1- filerCIK 0001087294
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 5:00 PM ET
- Size
- 4.5 KB